Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam tosylate vs etomidate for induction of general anesthesia in elderly hypertensive patients undergoing non-cardiac surgery
ChiCTR2200064997Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Guizhou Medical University
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam and etomidate in hypertension (HTN) (3 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoints: MAP change value during induction of general anesthesia, HR change value during induction of general anesthesia and 1 more. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
remimazolametomidate
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2200064997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064997.